AIC
IONS icon

Archer Investment Corporation’s Ionis Pharmaceuticals IONS Stock Holding History

Archer Investment Corporation’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.1K Hold
600
– – 0.01% 543
2025
Q4 		$47.5K Hold
600
– – 0.01% 479
2025
Q3 		$39.3K Hold
600
– – 0.01% 515
2025
Q2 		$23.7K Hold
600
– – 0.01% 576
2025
Q1 		$18.1K Hold
600
– – ﹤0.01% 598
2024
Q4 		$21K Hold
600
– – 0.01% 574
2024
Q3 		$24K Hold
600
– – 0.01% 547
2024
Q2 		$28.6K Sell
600
-250
-29% -$10.3K 0.01% 495
2024
Q1 		$36.8K Hold
850
– – 0.01% 444
2023
Q4 		$43K Hold
850
– – 0.01% 424
2023
Q3 		$38.6K Hold
850
– – 0.01% 417
2023
Q2 		$34.9K Hold
850
– – 0.01% 428
2023
Q1 		$30.4K Hold
850
– – 0.01% 436
2022
Q4 		$32.1K Hold
850
– – 0.01% 412
2022
Q3 		$37.6K Hold
850
– – 0.02% 377
2022
Q2 		$31.5K Hold
850
– – 0.01% 403
2022
Q1 		$33.7K Hold
850
– – 0.01% 411
2021
Q4 		$25.9K Sell
850
-67
-7% -$2.11K 0.01% 454
2021
Q3 		$30.8K Buy
+917
New +$34.6K 0.01% 416
2021
Q2 		– Sell
-917
Closed -$41.2K – 617
2021
Q1 		$41.2K Hold
917
– – 0.02% 367
2020
Q4 		$51.8K Hold
917
– – 0.02% 283
2020
Q3 		$43.5K Hold
917
– – 0.02% 274
2020
Q2 		$54.1K Hold
917
– – 0.03% 243
2020
Q1 		$43K Hold
917
– – 0.03% 244
2019
Q4 		$55K Hold
917
– – 0.03% 253
2019
Q3 		$55K Buy
917
+817
+817% +$53.2K 0.03% 229
2019
Q2 		$6K Hold
100
– – ﹤0.01% 370
2019
Q1 		$8K Hold
100
– – 0.01% 354
2018
Q4 		$5K Buy
+100
New +$5.1K ﹤0.01% 354

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Archer Investment Corporation's IONS Position: Q1 2026 in Review

Archer Investment Corporation held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 600 shares worth $45.1K. The position accounts for 0.01% of the portfolio, ranked #543.

Archer Investment Corporation first reported a position in IONS in Q4 2018 and has held it in 29 quarters since. The position peaked at $55K in Q4 2019. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Archer Investment Corporation held 600 shares of Ionis Pharmaceuticals worth $45.1K as of Q1 2026.
  • Archer Investment Corporation left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
  • Ionis Pharmaceuticals made up 0.01% of Archer Investment Corporation's portfolio in Q1 2026, its #543 holding.
  • Archer Investment Corporation first reported a position in Ionis Pharmaceuticals in Q4 2018 and has held it in 29 quarters since.
  • Archer Investment Corporation's Ionis Pharmaceuticals position peaked at $55K in Q4 2019.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Archer Investment Corporation's 13F filing for Q1 2026, filed 4 May 2026.